Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion type Assertion NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_head.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion description "[We have previously shown that glucose-dependent insulinotropic polypeptide (GIP) analogues that originally have been developed to treat diabetes have neuroprotective effects in the brains of the APPswe/PS1?E9 mouse model of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_provenance.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion evidence source_evidence_literature NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_provenance.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion SIO_000772 23568101 NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_provenance.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion wasDerivedFrom befree-2016 NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_provenance.
- NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_assertion wasGeneratedBy ECO_0000203 NP1067546.RAdDq2R77EVIkymVHt-JVqI57P7qqxMqIsbN6lWt42JxY130_provenance.